## **Core Concept**
Adenosine deaminase (ADA) deficiency is a genetic disorder that affects the immune system. It is caused by a deficiency of the enzyme adenosine deaminase, which is crucial for the breakdown of adenosine and deoxyadenosine in cells. This deficiency primarily affects lymphocytes, leading to severe combined immunodeficiency (SCID).

## **Why the Correct Answer is Right**
The correct answer, , is related to Severe Combined Immunodeficiency (SCID). ADA deficiency is a known cause of SCID, a condition where both B cells and T cells are severely impaired, leading to a significant susceptibility to infections. The deficiency leads to the accumulation of toxic metabolites, such as deoxyadenosine triphosphate (dATP), which particularly damages lymphocytes. This results in a profound deficiency in cell-mediated and humoral immunity.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to SCID or any condition directly related to ADA deficiency.
- **Option B:** This option is incorrect as it does not accurately represent the condition associated with ADA deficiency.
- **Option C:** This option is incorrect because, although it might seem plausible, it does not correctly identify SCID as the condition associated with ADA deficiency.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ADA deficiency is one of the causes of SCID, and it can be treated with enzyme replacement therapy (ERT), bone marrow transplantation, or gene therapy. Early diagnosis through newborn screening can significantly improve outcomes.

## **Correct Answer:** . SCID